Open an account

SI-BONE

SIBN · NASDAQ

$20.54+$0.88 (+4.48%)TodayMarket closed ·
Prev close $19.66

About SIBN

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 376 full-time employees. The company went IPO on 2018-10-17. The firm specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The firm's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The firm's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Employees
376
Headquarters
Santa Clara, California
Listed
Oct 17, 2018
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
si-bone.com

SIBN key statistics

Market cap
920.57M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
593.44K
Volume
640.68K
Open price
$19.90
High today
$20.59
Low today
$19.85
52 Week high
$21.89
52 Week low
$11.48

SI-BONE (SIBN) at a glance

As of Oct 20, 2026, SI-BONE (SIBN) shares are priced at $20.54, giving the company a market cap of 920.57M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $19.85 and $20.59. The current price is 3.5% above the day's low and 0.2% below its high.

Volume so far is 640.68K shares, in line with the average of 593.44K shares a day.

Over the past year SI-BONE has ranged from $11.48 to $21.89, and now sits 87% of the way up that range.

SI-BONE met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported -$0.09 per share against an estimate of -$0.1526.

The average analyst price target is $25.30, 23.2% above the current price, from 8 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 8 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 12 analystsAvg $25.30
Low
$20.20
Now
$20.54
High
$33.60

SIBN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 39.2% on average.

  1. Q3 FY24: reported -$0.16 per share against an estimate of -$0.2438
  2. Q4 FY24: reported -$0.11 per share against an estimate of -$0.1487
  3. Q1 FY25: reported -$0.15 per share against an estimate of -$0.2302
  4. Q2 FY25: reported -$0.14 per share against an estimate of -$0.1877
  5. Q3 FY25: reported -$0.11 per share against an estimate of -$0.1694
  6. Q4 FY25: reported -$0.04 per share against an estimate of -$0.1285
  7. Q1 FY26: reported -$0.10 per share against an estimate of -$0.1928
  8. Q2 FY26: reported -$0.09 per share against an estimate of -$0.1526

SIBN news

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • A Glimpse Into The Expert Outlook On SI-BONE Through 5 Analysts

  • 12 Health Care Stocks Moving In Tuesday's Intraday Session

  • Forecasting The Future: 6 Analyst Projections For SI-BONE

  • 12 Health Care Stocks Moving In Monday's After-Market Session

  • Avi Kapoor

    Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

  • Expert Outlook: SI-BONE Through The Eyes Of 5 Analysts

  • Press releaseBusiness Wire

    Bruker Appoints Laura Francis to its Board of Directors

Similar companies

Companies in the same industry as SI-BONE

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.